-
Something wrong with this record ?
How Are Infants Suspected to Have Cow's Milk Allergy Managed? A Real World Study Report
Y. Vandenplas, S. Belohlavkova, A. Enninger, P. Frühauf, N. Makwana, A. Järvi
Language English Country Switzerland
Document type Journal Article, Multicenter Study
NLK
Free Medical Journals
from 2009
PubMed Central
from 2009
Europe PubMed Central
from 2009
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2009-01-01
Open Access Digital Library
from 2009-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2009
PubMed
34578905
DOI
10.3390/nu13093027
Knihovny.cz E-resources
- MeSH
- Allergens immunology MeSH
- Milk Hypersensitivity diagnosis therapy MeSH
- Infant MeSH
- Humans MeSH
- Milk Proteins immunology MeSH
- Milk immunology MeSH
- Infant, Newborn MeSH
- Primary Health Care methods MeSH
- Prospective Studies MeSH
- Surveys and Questionnaires MeSH
- Animals MeSH
- Check Tag
- Infant MeSH
- Humans MeSH
- Male MeSH
- Infant, Newborn MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Geographicals
- Belgium MeSH
- Czech Republic MeSH
- Germany MeSH
- United Kingdom MeSH
The purpose of this study was to evaluate the diagnosis and management of infants presenting with symptoms attributable to cow's milk allergy (CMA) in a real life setting and to test how the Cow's Milk-related Symptom Score (CoMiSS®) can be used to support the awareness to diagnose cow's milk protein allergy in primary care practice. The CoMiSS is an awareness tool based on various symptoms such as crying, gastrointestinal symptoms, dermatological and respiratory symptoms. The study was conducted on 268 infants from four countries (Belgium, Czech Republic, Germany, UK) aged 0 to 18 months consulting for CMA related symptoms. The analysis was based on two visits of these subjects. The results show an average CoMiSS of 11 at the first visit. After a therapeutic dietary intervention, the score at the second visit, which happened 3 weeks ± 5 days after the first one, dropped to an average value of 4. A satisfaction questionnaire completed by the primary care practitioners suggested an overall high level of satisfaction with the application of the CoMiSS tool in routine practice. These data highlight a huge discrepancy in the diagnosis and management of infants suspected of CMA in the different countries. The findings suggest that the CoMISS questionnaire is an effective tool in aiding awareness of CMPA in primary health care.
Immuno flow s r o 12843 Prague Czech Republic
Nestlé Health Science 1800 Vevey Switzerland
Olgahospital Zentrum für Kinder Jugend und Frauenmedizin Klinikum Stuttgart 70174 Stuttgart Germany
Sandwell and West Birmingham Hospitals Birmingham B18 7QH UK
Vrije Universiteit Brussel UZ Brussel KidZ Health Castle 1090 Brussels Belgium
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003877
- 003
- CZ-PrNML
- 005
- 20240808092158.0
- 007
- ta
- 008
- 220113s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/nu13093027 $2 doi
- 035 __
- $a (PubMed)34578905
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Vandenplas, Yvan $u Vrije Universiteit Brussel (VUB), UZ Brussel, KidZ Health Castle, 1090 Brussels, Belgium
- 245 10
- $a How Are Infants Suspected to Have Cow's Milk Allergy Managed? A Real World Study Report / $c Y. Vandenplas, S. Belohlavkova, A. Enninger, P. Frühauf, N. Makwana, A. Järvi
- 520 9_
- $a The purpose of this study was to evaluate the diagnosis and management of infants presenting with symptoms attributable to cow's milk allergy (CMA) in a real life setting and to test how the Cow's Milk-related Symptom Score (CoMiSS®) can be used to support the awareness to diagnose cow's milk protein allergy in primary care practice. The CoMiSS is an awareness tool based on various symptoms such as crying, gastrointestinal symptoms, dermatological and respiratory symptoms. The study was conducted on 268 infants from four countries (Belgium, Czech Republic, Germany, UK) aged 0 to 18 months consulting for CMA related symptoms. The analysis was based on two visits of these subjects. The results show an average CoMiSS of 11 at the first visit. After a therapeutic dietary intervention, the score at the second visit, which happened 3 weeks ± 5 days after the first one, dropped to an average value of 4. A satisfaction questionnaire completed by the primary care practitioners suggested an overall high level of satisfaction with the application of the CoMiSS tool in routine practice. These data highlight a huge discrepancy in the diagnosis and management of infants suspected of CMA in the different countries. The findings suggest that the CoMISS questionnaire is an effective tool in aiding awareness of CMPA in primary health care.
- 650 _2
- $a alergeny $x imunologie $7 D000485
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mléko $x imunologie $7 D008892
- 650 _2
- $a alergie na mléko $x diagnóza $x terapie $7 D016269
- 650 _2
- $a mléčné bílkoviny $x imunologie $7 D008894
- 650 _2
- $a primární zdravotní péče $x metody $7 D011320
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 651 _2
- $a Belgie $7 D001530
- 651 _2
- $a Česká republika $7 D018153
- 651 _2
- $a Německo $7 D005858
- 651 _2
- $a Spojené království $7 D006113
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Belohlavkova, Simona $u Immuno-flow, s.r.o., 12843 Prague, Czech Republic
- 700 1_
- $a Enninger, Axel $u Olgahospital, Zentrum für Kinder-, Jugend- und Frauenmedizin, Klinikum Stuttgart, 70174 Stuttgart, Germany
- 700 1_
- $a Frühauf, Pavel, $u Pediatric Clinics and Inherited Metabolic Disorders, 1st Faculty of Medicine Charles University, 12108 Prague, Czech Republic $d 1951-2024 $7 jn20000400733
- 700 1_
- $a Makwana, Niten $u Sandwell and West Birmingham Hospitals, Birmingham B18 7QH, UK
- 700 1_
- $a Järvi, Anette $u Nestlé Health Science, 1800 Vevey, Switzerland
- 773 0_
- $w MED00189563 $t Nutrients $x 2072-6643 $g Roč. 13, č. 9 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34578905 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20240808092152 $b ABA008
- 999 __
- $a ok $b bmc $g 1751367 $s 1155026
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 13 $c 9 $e 20210830 $i 2072-6643 $m Nutrients $n Nutrients $x MED00189563
- LZP __
- $a Pubmed-20220113